Helex to present a poster on its proprietary lipid nanoparticles for targeted delivery to disease-relevant kidney cells, validated in rodents and non-human primates, at CGT International Europe, Berlin, Germany, November 3–5, 2026
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.